MedTrace Logo

System Accuracy of 12 Bloog Glucose Monitoring Systems

NCT05219526 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2023-09-08

No results posted yet for this study

Summary

The system accuracy of 12 blood glucose monitoring systems is to be evaluated randomly in accordance with DIN EN ISO 15197:2015 in the course of the year 2022.

Conditions

Interventions

DIAGNOSTIC_TEST

blood glucose measurement: BGM

measurement of blood glucose concentration using different BGM

DIAGNOSTIC_TEST

blood glucose measurement: reference method

measurement of blood glucose concentration using reference Method

Sponsors & Collaborators

  • Aktivmed GmbH

    collaborator UNKNOWN

  • Beurer GmbH

    collaborator UNKNOWN

  • IME-DC GmbH

    collaborator UNKNOWN

  • Medisana GmbH

    collaborator UNKNOWN

  • Institut fur Diabetes Karlsburg GmbH

    lead OTHER

Principal Investigators

  • Eckhard Salzsieder, PhD · Institut fur Diabetes Karlsburg GmbH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05219526 on ClinicalTrials.gov